The relationship between quality, spending, and outcomes among women with breast cancer

Journal of the National Cancer Institute

Volumn 106, Issue 10, 2014, Pages

  Hassett, Michael J ^a,b   Neville, Bridget A ^c   Weeks, Jane C ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ARIADNE LABS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; INTRADUCTAL CARCINOMA; LUMPECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; BREAST TUMOR; CANCER GRADING; ECONOMICS; MEDICAL FEE; MEDICARE; MORTALITY; TREATMENT OUTCOME; UNITED STATES; UNNECESSARY PROCEDURE; UTILIZATION REVIEW;

AGED; BREAST NEOPLASMS; FEE-FOR-SERVICE PLANS; FEMALE; HUMANS; MEDICARE; NEOPLASM GRADING; NEOPLASM STAGING; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; TREATMENT OUTCOME; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 84984950686     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju242     Document Type: Article

References (34)

1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220-241.
2. Hassett MJ, O'Malley AJ, Pakes JR, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.[see comment]. J Natl Cancer Inst. 2006;98(16):1108-1117.
3. Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888-897.
4. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-128.
5. Hassett MJ, Hughes ME, Niland JC, et al. Selecting high priority quality measures for breast cancer quality improvement.[see comment]. Med Care. 2008;46(8):762-770.
6. Hynes DM. The quality of breast cancer care in local communities: implications for health care reform. Med Care. 1994;32(4):328-340.
7. Malin JL, Schuster MA, Kahn KA, et al. Quality of breast cancer care: what do we know? J Clin Oncol. 2002;20(21):4381-4393.
8. Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston, MA: Harvard Business School Press; 2006.
9. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138(4):288-298.
10. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138(4):273-287.
11. Fisher E, Goodman D, Skinner J, et al. Health Care Spending, Quality, and Outcomes: More Isn't Always Better. A Dartmouth Atlas Project Topic Brief, 2009. http://www.dartmouthatlas.org/downloads/reports/Spending-Brief-022709.pdf. Accessed February 21, 2014.
12. Skinner JS, Staiger DO, Fisher ES. Is technological change in medicine always worth it? The case of acute myocardial infarction. Health Aff (Millwood). 2006;25(2):w34-w47.
13. Stukel TA, Fisher ES, Alter DA, et al. Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA. 2012;307(10):1037-1045.
14. Reeves D, Campbell SM, Adams J, et al. Combining multiple indicators of clinical quality: an evaluation of different analytic approaches. Med Care. 2007;45(6):489-496.
15. Landrum MB, Meara ER, Chandra A, et al. Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients. Health Aff (Millwood). 2008;27(1):159-168.
16. Hassett MJ, Weeks J. Identifying High Priority Quality Measures for Breast Cancer Quality Improvement Using Data From a Nationally Representative Sample. J Clin Oncol. 2009;27(15s):abstract 6507.
17. Jagsi R, Abrahamse P, Hawley ST, et al. Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data. Cancer. 2012;118(2):333-341.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-383.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidem. 1992;45(6):613-619.
20. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidem. 2000;53(12):1258-1267.
21. NCCN. NCCN Clinical Practice Guidelines in Oncology.
22. Services USDoHaH. Hospital Compare. 2011. www.hospitalcompare.hhs. gov.Accessed February 21, 2014.
23. Holmboe ES, Weng W, Arnold GK, et al. The comprehensive care project: measuring physician performance in ambulatory practice. Health Serv Res. 2010;45(6 Pt 2):1912-1933.
24. Normand SL, Wolf RE, Ayanian JZ, et al. Assessing the accuracy of hospital clinical performance measures. Med Decis Making. 2007;27(1):9-20.
25. Society AC. Breast Cancer Facts & Figures 2011-2012. In. Atlanta, GA; 2011.
26. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-2150.
27. Du XL, Lin CC, Johnson NJ, et al. Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. Cancer. 2011;117(14):3242-3251.
28. DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61(6):409-418.
29. Cheng SH, Wang CJ, Lin JL, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care. 2009;47(2):217-225.
30. Higashi T, Shekelle PG, Adams JL, et al. Quality of care is associated with survival in vulnerable older patients.[see comment][summary for patients in Ann Intern Med. 2005 Aug 16;143(4):I33; PMID: 16103467]. Ann Intern Med. 2005;143(4):274-281.
31. Zuckerman S, Waidmann T, Berenson R, et al. Clarifying sources of geographic differences in Medicare spending. N Engl J Med. 2010;363(1):54-62.
32. Brooks GA, Li L, Sharma DB, et al. Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst. 2013;105(9):634-642.
33. Keating NL, Landrum MB, Lamont EB, et al. Area-level variations in cancer care and outcomes. Med Care. 2012;50(5):366-373.
34. ABIM Foundation. Choosing Wisely. http://choosingwisely.org/. Accessed February 21, 2014.